BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 19661462)

  • 1. Using lidocaine and benzocaine to link sodium channel molecular conformations to state-dependent antiarrhythmic drug affinity.
    Hanck DA; Nikitina E; McNulty MM; Fozzard HA; Lipkind GM; Sheets MF
    Circ Res; 2009 Aug; 105(5):492-9. PubMed ID: 19661462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outward stabilization of the S4 segments in domains III and IV enhances lidocaine block of sodium channels.
    Sheets MF; Hanck DA
    J Physiol; 2007 Jul; 582(Pt 1):317-34. PubMed ID: 17510181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Charge at the lidocaine binding site residue Phe-1759 affects permeation in human cardiac voltage-gated sodium channels.
    McNulty MM; Edgerton GB; Shah RD; Hanck DA; Fozzard HA; Lipkind GM
    J Physiol; 2007 Jun; 581(Pt 2):741-55. PubMed ID: 17363383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Block of inactivation-deficient Na+ channels by local anesthetics in stably transfected mammalian cells: evidence for drug binding along the activation pathway.
    Wang SY; Mitchell J; Moczydlowski E; Wang GK
    J Gen Physiol; 2004 Dec; 124(6):691-701. PubMed ID: 15545401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sodium channel molecular conformations and antiarrhythmic drug affinity.
    Sheets MF; Fozzard HA; Lipkind GM; Hanck DA
    Trends Cardiovasc Med; 2010 Jan; 20(1):16-21. PubMed ID: 20685573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lidocaine alters activation gating of cardiac Na channels.
    Hanck DA; Makielski JC; Sheets MF
    Pflugers Arch; 2000 Apr; 439(6):814-21. PubMed ID: 10784357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Important Role of Asparagines in Coupling the Pore and Votage-Sensor Domain in Voltage-Gated Sodium Channels.
    Sheets MF; Fozzard HA; Hanck DA
    Biophys J; 2015 Dec; 109(11):2277-86. PubMed ID: 26636939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common molecular determinants of local anesthetic, antiarrhythmic, and anticonvulsant block of voltage-gated Na+ channels.
    Ragsdale DS; McPhee JC; Scheuer T; Catterall WA
    Proc Natl Acad Sci U S A; 1996 Aug; 93(17):9270-5. PubMed ID: 8799190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Setting up for the block: the mechanism underlying lidocaine's use-dependent inhibition of sodium channels.
    Cummins TR
    J Physiol; 2007 Jul; 582(Pt 1):11. PubMed ID: 17525109
    [No Abstract]   [Full Text] [Related]  

  • 10. Local anaesthetic block of sodium channels: raising the barrier.
    Scheuer T
    J Physiol; 2007 Jun; 581(Pt 2):423. PubMed ID: 17412761
    [No Abstract]   [Full Text] [Related]  

  • 11. Kinetic effects of quaternary lidocaine block of cardiac sodium channels: a gating current study.
    Hanck DA; Makielski JC; Sheets MF
    J Gen Physiol; 1994 Jan; 103(1):19-43. PubMed ID: 8169596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atomic determinants of state-dependent block of sodium channels by charged local anesthetics and benzocaine.
    Tikhonov DB; Bruhova I; Zhorov BS
    FEBS Lett; 2006 Nov; 580(26):6027-32. PubMed ID: 17070808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. State- and use-dependent block of muscle Nav1.4 and neuronal Nav1.7 voltage-gated Na+ channel isoforms by ranolazine.
    Wang GK; Calderon J; Wang SY
    Mol Pharmacol; 2008 Mar; 73(3):940-8. PubMed ID: 18079277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrostatic contributions of aromatic residues in the local anesthetic receptor of voltage-gated sodium channels.
    Ahern CA; Eastwood AL; Dougherty DA; Horn R
    Circ Res; 2008 Jan; 102(1):86-94. PubMed ID: 17967784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Nav1.7 channel mutation associated with hereditary erythromelalgia contributes to neuronal hyperexcitability and displays reduced lidocaine sensitivity.
    Sheets PL; Jackson JO; Waxman SG; Dib-Hajj SD; Cummins TR
    J Physiol; 2007 Jun; 581(Pt 3):1019-31. PubMed ID: 17430993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular determinants of state-dependent block of voltage-gated sodium channels by pilsicainide.
    Desaphy JF; Dipalma A; Costanza T; Bruno C; Lentini G; Franchini C; George A; Conte Camerino D
    Br J Pharmacol; 2010 Jul; 160(6):1521-33. PubMed ID: 20590641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered gating and local anesthetic block mediated by residues in the I-S6 and II-S6 transmembrane segments of voltage-dependent Na+ channels.
    Kondratiev A; Tomaselli GF
    Mol Pharmacol; 2003 Sep; 64(3):741-52. PubMed ID: 12920212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Irreversible block of cardiac mutant Na+ channels by batrachotoxin.
    Wang SY; Tikhonov DB; Mitchell J; Zhorov BS; Wang GK
    Channels (Austin); 2007; 1(3):179-88. PubMed ID: 18690024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. State-dependent trapping of flecainide in the cardiac sodium channel.
    Ramos E; O'leary ME
    J Physiol; 2004 Oct; 560(Pt 1):37-49. PubMed ID: 15272045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A revised view of cardiac sodium channel "blockade" in the long-QT syndrome.
    Kambouris NG; Nuss HB; Johns DC; Marbán E; Tomaselli GF; Balser JR
    J Clin Invest; 2000 Apr; 105(8):1133-40. PubMed ID: 10772658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.